Camrelizumab combined with furquetinib or regorafenib in the treatment of second-line and later-line BRAF mutation-positive, microsatellite stable advanced colorectal cancer: a prospective clinical study
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2703237
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Case series:Carrelizumab combined with furquetinib or regorafenib
Primary outcome(s): PFS
Study Design: Single arm
创建时间：
2021-02-15
